![[up]](/style/images/multi_up.png)
Up a level2017
Cabarrou, Bastien
, Sfumato, Patrick, Mourey, Loïc, Leconte, Eve, Balardy, Laurent, Delord, Jean-Pierre, Boher, Jean-Marie and Filleron, Thomas
(2017)
Comment prendre en compte l’hétérogénéité dans le schéma des essais cliniques de phase II en oncogériatrie ?
Revue d'Epidémiologie et de Santé Publique, 65 (Supplément).
S60-S60.
2018
Cabarrou, Bastien, Sfumato, Patrick, Mourey, Loïc, Leconte, Eve and Balardy, Laurent
(2018)
Addressing heterogeneity in the design of phase II clinical trials in geriatric oncology.
European Journal of Cancer, vol. 103.
pp. 120-126.
2022
Cabarrou, Bastien, Leconte, Eve, Sfumato, Patrick, Boher, Jean-Marie and Filleron, Thomas
(2022)
A stratified adaptive two-stage design with co-primary endpoints for phase II clinical oncology trials.
BMC Medical Research Methodology, vol. 22 (n° 278).
